Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response

Journal of Cellular Biochemistry

Volumn 92, Issue 4, 2004, Pages 664-678

  Sharp, Z Dave ^b   Stenoien, David L ^a,c   Mancini, Maureen G ^a   Ouspenski, Ilia I ^a,d   Mancini, Michael A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cell stress; Chromatin; Photobleaching chaperone; Protein folding; Transcription; Ubiquitin

Indexed keywords

HEAT SHOCK PROTEIN 70; TRANSCRIPTION FACTOR PIT 1; DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; POU1F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BLEACHING; EXTRACELLULAR MATRIX; GENE INACTIVATION; GENE MUTATION; HEAT SHOCK; HUMAN; MOLECULAR DYNAMICS; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN INTERACTION; PROTEIN STRUCTURE; WILD TYPE; CELL NUCLEUS; CHROMATIN; COMPARATIVE STUDY; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; METABOLISM; MUTAGENESIS; PHYSIOLOGY; PROTEIN FOLDING;

CELL NUCLEUS; CHROMATIN; DNA-BINDING PROTEINS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HOMEODOMAIN PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MUTAGENESIS; PHOTOBLEACHING; POINT MUTATION; PROTEIN FOLDING; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 16644382499     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20028     Document Type: Article

References (51)

1. Andersen B, Rosenfeld MG. 1994. Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269:29335-29338.
2. Andersen B, Rosenfeld MG. 2001. POU domain factors in the neuroendocrine system: Lessons from developmental biology provide insights into human disease. Endocr Rev 22:2-35.
3. Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A. 1996. GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element. J Biol Chem 271:24639-24648.
4. Bradford AP, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A. 1997. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 17:1065-1074.
5. Bradford AP, Brodsky KS, Diamond SE, Kuhn LC, Liu Y, Gutierrez-Hartmann A. 2000. The Pit-1 homeodomain and β-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter. J Biol Chem 275:3100-3106.
6. Brown MR, Parks JS, Adess ME, Rich BH, Rosenthal IM, Voss TC, VanderHeyden TC, Hurley DL. 1998. Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 49:98-102.
7. Chuang FM, West BL, Baxter JD, Schaufele F. 1997. Activities in Pit-1 determine whether receptor interacting protein 140 activates or inhibits Pit-1/nuclear receptor transcriptional synergy. Mol Endocrinol 11: 1332-1341.
8. Cohen LE, Wondisford FE, Radovick S. 1996. Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin. Endocrinol Metab Clin North Am 25:523-540.
9. Cotto J, Fox S, Morimoto R. 1997. HSF1 granules: A novel stress-induced nuclear compartment of human cells. J Cell Sci 110(Pt 23):2925-2934.
10. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. 1998. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19:148-154.
11. Cummings CJ, Orr HT, Zoghbi HY. 1999. Progress in pathogenesis studies of spinocerebellar ataxia type 1. Philos Trans R Soc Lond B Biol Sci 354:1079-1081.
12. Dasen JS, Rosenfeld MG. 1999. Combinatorial codes in signaling and synergy: Lessons from pituitary development. Curr Opin Genet Dev 9:566-574.
13. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, Szeto DP, Hooshmand F, Aggarwal AK, Rosenfeld MG. 1999. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97:587-598.
14. Day RN. 1998. Visualization of Pit-1 transcription factor interactions in the living cell nucleus by fluorescence resonance energy transfer microscopy. Mol Endocrinol 12:1410-1419.
15. Day RN, Koike S, Sakai M, Muramatsu M, Maurer RA. 1990. Both Pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 4:1964-1971.
16. Ding Y, Lu W, Roberson MS, Moye-Rowley WS, Maurer RA. 1991. The tissue-specific mammalian transcription factor, Pit-1, activates transcription in Saccharomyces cerevisiae. Mol Endocrinol 5:1239-1245.
17. Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101-106.
18. Fujimoto N, Maruyama S, Ito A. 1999. Establishment of an estrogen responsive rat pituitary cell sub-line MtT/E-2. Endocr J 46:389-396.
19. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG. 1995. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 9:1992-2006.
20. Howard PW, Maurer RA. 1995. A composite Ets/Pit-1 binding site in the prolactin gene can mediate transcriptional responses to multiple signal transduction pathways. J Biol Chem 270:20930-20936.
21. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG. 1988. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55:519-529.
22. Kim S, Nollen EA, Kitagawa K, Bindokas VP, Morimoto RI. 2002. Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4:826-831.
23. Kioussi C, Carriere C, Rosenfeld MG. 1999. A model for the development of the hypothalamic-pituitary axis: Transcribing the hypophysis. Mech Dev 81:23-35.
24. Krobitsch S, Lindquist S. 2000. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci USA 97:1589-1594.
25. Li S, Crenshaw EBd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. 1990. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533.
26. Liang J, Moye-Rowley S, Maurer RA. 1995. In vivo mutational analysis of the DNA binding domain of the tissue-specific transcription factor, Pit-1. J Biol Chem 270:25520-25525.
27. Lin X, Cummings CJ, Zoghbi HY. 1999. Expanding our understanding of polyglutamine diseases through mouse models. Neuron 24:499-502.
28. Mancini MG, Liu B, Sharp ZD, Mancini MA. 1999. Subnuclear partitioning and functional regulation of the Pit-1 transcription factor. J Cell Biochem 72:322-338.
29. McNally JG, Muller WG, Walker D, Wolford R, Hager GL. 2000. The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells. Science 287:1262-1265.
30. Nollen EA, Morimoto RI. 2002. Chaperoning signaling pathways: Molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 115:2809-2816.
31. Nye AC, Rajendran RR, Stenoien DL, Mancini MA, Katzenellenbogen BS, Belmont AS. 2002. Alteration of large-scale chromatin structure by estrogen receptor. Mol Cell Biol 22:3437-3449.
32. Pfaffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA. 1992. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 257:1118-1121.
33. Phair RD, Misteli T. 2000. High mobility of proteins in the mammalian cell nucleus. Nature 404:604-609.
34. Radovick S, Cohen LE, Wondisford FE. 1998. The molecular basis of hypopituitarism. Horm Res 49:30-36.
35. Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM, Morimoto RI. 2000. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci USA 97: 5750-5755.
36. Schaufele F. 1999. Regulation of estrogen receptor activation of the prolactin enhancer/promoter by antagonistic activation function-2-interacting proteins. Mol Endocrinol 13:935-945.
37. Schonemann MD, Ryan AK, Erkman L, McEvilly RJ, Bermingham J, Rosenfeld MG. 1998. POU domain factors in neural development. Adv Exp Med Biol 449:39-53.
38. Scully KM, Rosenfeld MG. 2002. Pituitary development: Regulatory codes in mammalian organogenesis. Science 295:2231-2235.
39. Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG. 2000. Allosteric effects of pit-1 DNA sites on long-term repression in cell type. Science 290:1127-1131.
40. Sharp ZD. 1995. Rat Pit-1 stimulates transcription in vitro by influencing pre-initiation complex assembly. Biochem Biophys Res Commun 206:40-45.
41. Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A. 2000. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9:133-144.
42. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW. 1990. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 4:695-711.
43. Smith KP, Liu B, Scott C, Sharp ZD. 1995. Pit-1 exhibits a unique promoter spacing requirement for activation and synergism. J Biol Chem 270:4484-4491.
44. Stenoien DL, Cummings CJ, Adams HP, Mancini MG, Patel K, DeMartino GN, Marcelli M, Weigel NL, Mancini MA. 1999. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet 8:731-741.
45. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA. 2000. Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1. Mol Endocrinol 14:518-534.
46. Stenoien DL, Nye AC, Mancini MG, Patel K, Dutertre M, O'Malley BW, Smith CL, Belmont AS, Mancini MA. 2001a. Ligand-mediated assembly and real-time cellular dynamics of estrogen receptor α-coactivator complexes in living cells. Mol Cell Biol 21:4404-4412.
47. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA. 2001b. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent. Nat Cell Biol 3:15-23.
48. Stenoien DL, Mielke M, Mancini MA. 2002. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol 4:806-810.
49. Theill LE, Karin M. 1993. Transcriptional control of GH expression and anterior pituitary development. Endocr Rev 14:670-689.
50. Treier M, Rosenfeld MG. 1996. The hypothalamic-pituitary axis: Co-development of two organs. Curr Opin Cell Biol 8:833-843.
51. Xu L, Lavinsky RM, Dasen JS, Flynn SE, McInerney EM, Mullen TM, Heinzel T, Szeto D, Korzus E, Kurokawa R, Aggarwal AK, Rose DW, Glass CK, Rosenfeld MG. 1998. Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395:301-306.